04-Jun-2021 | Facts and Factors
We recently published a new market report named global In-vitro Toxicology Testing Market which incorporates the most recent offers. With a CAGR of 10.7%, we anticipate a market value of USD 9.7 Billion in 2020, rising to USD 16.1 Billion in 2026.
In-vitro toxicology is the process of regulating the effects that toxic chemicals and substances can have on a batch of lab-grown bacteria or any set of mammalian cells. These methods usually refer to the identification of harmful compounds in order to confirm the absence of a trait in the initial stages of a drug developmental process. The driving forces for the in-vitro toxicology testing market can be attributed to the advancements of 3D cell culture systems that are derived from the host physiology that limits animal testing.
Moreover, ongoing trends of a rise of in-vitro toxicology testing and high throughput testing produced at a cheaper and cost-effective method will boost the sales of the in-vitro toxicology testing market to a larger footprint. Additional factors such as early detection of hazardous substances in the initial trials have further integrated in-vitro toxicology devices to a higher volume of sales.
Top Market Players
The key participants in the global in-vitro toxicology testing market are Quest Diagnostic Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentonix, and Agilent Technologies, among others.
Here are some noteworthy developments in the in-vitro toxicology technology market during the forecast period –
- Abbott signed an exclusivity agreement with Intoximeters which would give the firm exclusive distribution rights for Abbott’s SoToxa Mobile Testing System – A handheld device that provides drug and alcohol testing means.
- SGS SA recently launched the new in-vitro testing which possesses developmental cell/tissue culture capabilities along with flow cytometry and mass spectrometry abilities. The device further boasts of high throughput screening, automation, and multiplexing technologies.
The global in-vitro toxicology testing market can be divided into systemic toxicology, dermal toxicology, endocrine disruption, ocular toxicity, and others on the basis of application. The segment headed by systemic toxicology will witness the highest market share during the forecast owing to contributing factors ranging from development of multiple organ plate assessment for systemic drives coupled with rising adoption of awareness of animal testing measures.
The global in-vitro toxicology testing market can be fragmented into pharmaceutical, cosmetics, and household products, diagnostics, chemicals industry & food industry on the basis of end-users. The pharmaceutical segment will account for the largest market share during the forecast owing to a rise of toxicology tests in pharmacokinetic analysis of novel and generic modified pharmaceutical testing.
Asia-Pacific Will Lead The Global In-Vitro Toxicology Testing Market During the Forecast Timeframe
Asia-Pacific is expected to recoup the largest market share during the forecast in terms of global revenue collection. Factors pertaining to increase of government spending in terms of research and developmental measures coupled with ongoing pressure to decrease animal testing in in-vitro testing. Factors such as low testing and cost-effectiveness mean in the region coupled with the presence of key players in the region will boost the sales of in-vitro toxicology testing.
Browse the full “In-Vitro Toxicology Testing Market By Product (Consumables, Assays, Equipment, Software, & Services), By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, & OMICS Technology), By Method (Cellular Assay, Biochemical Assay, In silico, & Ex-vivo), By Application (Systemic Toxicology, Dermal Toxicology, Endocrine Disruption, Ocular Toxicity, & Others), By End-User (Pharmaceutical, Cosmetics, and Household Products, Diagnostics, Chemicals Industry, & Food industry), And By Regions – Global And Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” report at https://www.fnfresearch.com/in-vitro-toxicology-testing-market.
The global in-vitro toxicology testing market can be segmented into:
Global In-Vitro Toxicology Testing Market: By Product Segment Analysis
- Bacterial Toxicity Assay
- Enzyme Toxicity Assay
- Cell-Based Elisa & Western Blots
- Receptor-Binding Assays
- Other Assays
Global In-Vitro Toxicology Testing Market: By Technology Segment Analysis
- Cell Culture Technology
- High Throughput Technology
- Molecular Imaging
- OMICS Technology
Global In-Vitro Toxicology Testing Market: By Method Segment Analysis
- Cellular Assay
- Biochemical Assay
- In silico
Global In-Vitro Toxicology Testing Market: By Application Segment Analysis
- Systemic Toxicology
- Dermal Toxicology
- Endocrine Disruption
- Ocular Toxicity
Global In-Vitro Toxicology Testing Market: By End-Users Segment Analysis
- Cosmetics and Household Products
- Chemicals Industry
- Food industry
Global In-Vitro Toxicology Testing Market: By Regional Segment Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
A 2108, Sargam,
Pune 411041, India